One missing as village largely destroyed in Swiss glacier collapse
A massive glacier collapse in the Swiss Alps on Wednesday largely destroyed the village of Blatten, with one person missing, authorities said.
The village in the Lotschental valley, home to 300 people, had been evacuated last week due to the impending danger.
The huge collapse on the Birch Glacier in Switzerland's southern Wallis region happened at around 3:30 pm.
Officials said the missing person, a 64-year-old man, was not one of the evacuated residents, and added that there were no known injuries.
"The unimaginable has happened," Blatten's president Matthias Bellwald told a press conference.
"We have lost our village, but not our hearts.
"Even though the village lies under a huge pile of rubble, we know where our homes and our church must be rebuilt," he added.
The glacier collapse had been expected for several days.
Footage posted on YouTube showed a huge cloud of ice and scree hurtling down the mountain slope and into the valley where the village is located. The mud and rockfall hit the houses.
"The worst-case scenario has occurred," said Raphael Mayoraz, head of the Wallis canton's Natural Hazards Service.
He said three million cubic metres of material had accumulated on the glacier, and then tumbled down into the valley.
"This is a very rare event," he said. "We don't know exactly what's still up there, but most of it has fallen."
- Search and rescue effort -
Swiss national broadcaster RTS aired drone footage showing the debris had subsumed and smashed buildings, and pushed homes into one another.
Wallis police said the missing 64-year-old man was a local resident who, according to their information, was in the area at the time of the incident.
A search and rescue operation was launched, with three rescue specialists airlifted to the scene, while a drone with a thermal imaging camera was also used.
"Despite significant efforts, the man has still not been found," police said.
Mayoraz said a blockage two kilometres long had formed in the valley floor, where the Lonza river flows, with a small lake growing behind it.
"It's like a small mountain," he said.
Though unlikely, a debris flow cannot be ruled out completely, he added.
"That's a risk we have to monitor," he said.
- 'Nature is stronger' -
"It's terrible to lose your home. In these difficult times, my thoughts are with the residents of Blatten," Swiss President Karin Keller-Sutter wrote on X.
Two of Switzerland's seven government ministers, defence and civil protection minister Martin Pfister and environment minister Albert Rosti, went to the valley.
Pfister called it a disaster of "striking proportions".
"We assure you of our support, today and in the weeks and probably years to come," he told the press conference, adding that the army was on its way.
Rosti said the government "will do everything possible to give Blatten a future, although it will take a lot of effort and time".
"Nature is stronger than humankind, as mountain dwellers know," he added.
A significant increase in activity was observed on the glacier from Tuesday night and intensified during Wednesday.
The Alps mountain range in Europe has seen its glaciers retreat in recent years due to warming that most scientists attribute to climate change.
Swiss glaciers, severely impacted by climate change, melted as much in 2022 and 2023 as between 1960 and 1990, losing in total about 10 percent of their volume.
vog-rjm/giv
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
U.S.-backed Gaza aid group pauses work amid reported killings
The controversial U.S.-backed humanitarian aid operation in Gaza, which has been mired by reports of dozens of Palestinians being killed trying to reach its distribution hubs in the war-torn enclave since it started work just over a week ago, said it was pausing its operations for Wednesday. The Gaza Humanitarian Foundation said in a statement posted on social media that the pause was "for update, organization, and efficiency improvement work," but a spokesperson for the group said it was working to address security concerns. GHF said in its brief statement that operations would resume on Thursday. The United Nations and other aid agencies have refused to work with the group, calling it a distraction and accusing it of weaponizing access to desperately needed food. More than 50 people have been killed by Israeli forces near the sites, according to Gaza's Hamas-run Ministry of Health, which has called the GHF effort a trap for hungry Palestinians. The Israeli military has denied the accusations and accused Hamas of shooting at people seeking aid. The funding, operational details and origins of the GHF have remained murky since its inception, and it has been plagued not only by grave questions about security for civilians accessing its hubs, but by potentially existential issues regarding its internal operations. The move comes just days after GHF said it would shutter its Switzerland-based office after officials there told CBS News the foundation was violating Swiss rules for non-governmental organizations. It also comes just a day after The Washington Post reported that U.S.-based consulting firm Boston Global had severed its ties with the group and launched an internal review over its involvement with GHF. GHF said it began work in Gaza on May 27, but it remains unclear where it is based and who is funding its operations. Its official website consists only of a homepage bearing its name and the message: "More information coming soon." A GHF spokesperson told CBS News in a statement sent Wednesday that the group was "actively engaged in discussions with" Israel's military aimed at enhancing security "beyond the immediate perimeter of GHF sites." The organization said it had asked the Israel Defense Forces to "guide foot traffic in a way that minimizes confusion or escalation risks" around its ongoing military operations in Gaza, to offer clearer guidance for civilians seeking to reach its distribution hubs, and to "enhance IDF force training and refine internal IDF procedures to support safety." "Our top priority remains ensuring the safety and dignity of civilians receiving aid," the spokesperson said in the statement, which was also shared with other news outlets. Health officials in the Hamas-ruled Gaza Strip said 27 Palestinians were killed trying to reach a GHF hub in southern Gaza on Tuesday alone. The Israeli military denied the claim of mass shooting at civilians, saying troops about a third of a mile away from the site had fired at several people who were deemed to present a threat after they strayed beyond the defined boundaries of the access route. The IDF said it was looking into the reports of civilian casualties. In a message posted Wednesday on social media in Arabic, IDF spokesperson Lt. Col. Avichay Adraee warned Gazans against using the roads leading to GHF distribution centers, saying they would be considered "combat zones" for the day and stressing that access to them was "prohibited and dangerous." The IDF has repeatedly accused Hamas of sabotaging the GHF effort, accusing it of sending gunmen specifically to shoot at civilians at the aid hubs. "We are not preventing Gaza residents from accessing aid distribution sites," IDF spokesperson Brig. Gen. Effie Defrin said in a video statement posted online Tuesday, before the one-day pause was reported. "Food packages are being distributed daily by a U.S.-based civilian company. This initiative is proving effective. Gazan residents are coming to the distribution centers to receive the aid. The civilian population of Gaza understands that Hamas is not taking care of them — on the contrary, Hamas is actively trying to prevent them from receiving the aid." Defrin said IDF forces "operate nearby and do whatever is necessary to ensure that the aid does not fall into the hands of Hamas." He also accused the United Nations' aid agencies of failing to collect and distribute more than 450 trucks carrying humanitarian aid that Israel says were allowed into Gaza in recent days but left waiting on the other side of the Kerem Shalom border crossing with Israel. The U.N. has rejected similar previous Israeli claims, noting that Israeli forces maintain control over virtually all of Gaza and that there are huge logistics challenges to operating in a densely populated active warzone. And the IDF's assault, which Israel has vowed to continue until Hamas is destroyed and the remaining 58 Israeli hostages are brought back home from Gaza, has continued to ramp up despite the U.S.-backed aid effort. CBS News' team in Gaza was there as Palestinians rushed to rescue survivors of an Israeli strike that destroyed a bank in Gaza City where families had taken shelter. At least seven people were killed and dozens injured, according to first responders who spoke with CBS News at the scene. They were among 97 Palestinians killed over the preceding 24 hours alone, according to the Hamas-run Gaza Ministry of Health, which put the overall death toll from the war at 54,607 as of Wednesday. The war was sparked by the Oct. 7, 2023, attack on southern Israel orchestrated by Hamas, which has long been designated a terrorist group by the U.S., Israel and the European Union. That attack killed some 1,200 people in Israel and saw 251 others taken hostage into Gaza. Israeli authorities believe about 20 of the remaining hostages are still alive. January 6 defendant refuses Trump's pardon Sneak peek: Where is Jermain Charlo? Baldwin grills McMahon on unallocated funds for students, schools, approved by Congress


CBS News
3 hours ago
- CBS News
U.S.-backed Gaza aid group halts work for a day, reportedly asks Israel to minimize risks to Palestinians
The controversial U.S.-backed humanitarian aid operation in Gaza, which has been mired by reports of dozens of Palestinians being killed trying to reach its distribution hubs in the war-torn enclave since it started work just over a week ago, said it was pausing its operations for Wednesday. The Gaza Humanitarian Foundation said in a statement posted on social media that the pause was "for update, organization, and efficiency improvement work," but the Reuters news agency said the U.S. entity was trying to address security concerns. GHF said in its brief statement that operations would resume on Thursday. The United Nations and other aid agencies have refused to work with the group, calling it a distraction and accusing it of weaponizing access to desperately needed food. More than 50 people have been killed by Israeli forces near the sites, according to Gaza's Hamas-run Ministry of Health, which has called the GHF effort a trap for hungry Palestinians. The Israeli military has denied the accusations and accused Hamas of shooting at people seeking aid. GHF did not immediately respond to a CBS News request for more information on the one-day shutdown of its four distribution hubs in southern Gaza. Palestinian children carry pots as they wait for a hot meal at a food distribution point in Nuseirat, in the central Gaza Strip, run by international charity groups, June 4, 2025. EYAD BABA/AFP/Getty The funding, operational details and origins of the GHF have remained murky since its inception, and it has been plagued not only by grave questions about security for civilians accessing its hubs, but by potentially existential issues regarding its internal operations. The move comes just days after GHF said it would shutter its Switzerland-based office after officials there told CBS News the foundation was violating Swiss rules for non-governmental organizations. It also comes just a day after The Washington Post reported that U.S.-based consulting firm Boston Global had severed its ties with the group and launched an internal review over its involvement with GHF. GHF said it began work in Gaza on May 27, but it remains unclear where it is based and who is funding its operations. Its official website consists only of a homepage bearing its name and the message: "More information coming soon." The Reuters news agency quoted an unnamed GHF spokesperson on Wednesday as saying the group had asked the Israel Defense Forces to "guide foot traffic in a way that minimizes confusion or escalation risks" around its ongoing military operations in Gaza, and to develop more clear guidance for civilians seeking to reach its distribution hubs, and to "enhance training to support civilian safety." "Our top priority remains ensuring the safety and dignity of civilians receiving aid," Reuters quoted a GHF spokesperson as saying. Health officials in the Hamas-ruled Gaza Strip said 27 Palestinians were killed trying to reach a GHF hub in southern Gaza on Tuesday alone. The Israeli military denied the claim of mass shooting at civilians, saying troops about a third of a mile away from the site had fired at several people who were deemed to present a threat after they strayed beyond the defined boundaries of the access route. The IDF said it was looking into the reports of civilian casualties. In a message posted Wednesday on social media in Arabic, IDF spokesperson Lt. Col. Avichay Adraee warned Gazans against using the roads leading to GHF distribution centers, saying they would be considered "combat zones" for the day and stressing that access to them was "prohibited and dangerous." The IDF has repeatedly accused Hamas of sabotaging the GHF effort, accusing it of sending gunmen specifically to shoot at civilians at the aid hubs. "We are not preventing Gaza residents from accessing aid distribution sites," IDF spokesperson Brig. Gen. Effie Defrin said in a video statement posted online Tuesday, before the one-day pause was reported. "Food packages are being distributed daily by a U.S.-based civilian company. This initiative is proving effective. Gazan residents are coming to the distribution centers to receive the aid. The civilian population of Gaza understands that Hamas is not taking care of them — on the contrary, Hamas is actively trying to prevent them from receiving the aid." Defrin said IDF forces "operate nearby and do whatever is necessary to ensure that the aid does not fall into the hands of Hamas." He also accused the United Nations' aid agencies of failing to collect and distribute more than 450 trucks carrying humanitarian aid that Israel says were allowed into Gaza in recent days but left waiting on the other side of the Kerem Shalom border crossing with Israel. The U.N. has rejected similar previous Israeli claims, noting that Israeli forces maintain control over virtually all of Gaza and that there are huge logistics challenges to operating in a densely populated active warzone. And the IDF's assault, which Israel has vowed to continue until Hamas is destroyed and the remaining 58 Israeli hostages are brought back home from Gaza, has continued to ramp up despite the U.S.-backed aid effort. CBS News' team in Gaza was there as Palestinians rushed to rescue survivors of an Israeli strike that destroyed a bank in Gaza City where families had taken shelter. At least seven people were killed and dozens injured, according to first responders who spoke with CBS News at the scene. They were among 97 Palestinians killed over the preceding 24 hours alone, according to the Hamas-run Gaza Ministry of Health, which put the overall death toll from the war at 54,607 as of Wednesday. The war was sparked by the Oct. 7, 2023, attack on southern Israel orchestrated by Hamas, which has long been designated a terrorist group by the U.S., Israel and the European Union. That attack killed some 1,200 people in Israel and saw 251 others taken hostage into Gaza. Israeli authorities believe about 20 of the remaining hostages are still alive.
Yahoo
8 hours ago
- Yahoo
TOLREMO therapeutics Announces TT125-802 is the First CBP/p300 Bromodomain Inhibitor to Show Clinical Activity in Solid Tumors
- Deep and durable responses in drug-resistant KRAS-G12C- and EGFR-mutant NSCLC - Best-in-class safety profile highlights potential for development in combination to treat patients with KRAS-G12C-mutant NSCLC, EGFR-mutant NSCLC and R/R multiple myeloma Basel, June 04, 2025 – TOLREMO therapeutics AG (TOLREMO), a clinical stage biotechnology company pioneering non-oncogene addiction in cancer, today announced data from its ongoing Phase I study of TT125-802, a novel, orally administered bromodomain inhibitor of CBP/p300, for patients with advanced solid tumors who have relapsed or are refractory to standard-of-care therapies, including an abstract published at the 2025 American Society of Clinical Oncology (ASCO) annual meeting. Updated data from the study was discussed at TOLREMO's SAB meeting during ASCO and recorded in a virtual ASCO data update. To date TT125-802 shows impressive anti-tumor activity in advanced solid tumors, including deep and durable responses in non-small cell lung cancer (NSCLC). In addition, TT125-802 demonstrates a best-in-class safety profile without thrombocytopenia, the primary toxicity associated with its class of inhibitors. 'Five out of seven NSCLC patients on this study experienced tumor shrinkage following progression on their prior therapy. The two patients with KRAS-G12C- or EGFR-mutant NSCLC – the two tumor types we had preclinically selected as target indications - each showed deep and durable responses to single agent TT125-802. There remains a large and urgent need for more effective and tolerable therapies, and TT125-802 has the potential to offer an improved therapeutic option through resistance-targeted combinations," said Florian Vogl, M.D., PhD, Chief Medical Officer at TOLREMO. 'EGFR- and KRAS-targeted therapies have historically been limited by intrinsic and acquired resistance. Inhibiting transcriptional mechanisms of resistance via CBP/p300 represents an exciting and much needed opportunity for more effective and tolerable therapies. TT125-802 has shown impressive activity in NSCLC even as a monotherapy, and I look forward to combining the drug with EGFR and KRAS-G12C inhibitors to provide better treatment options to my patients,' added Pasi Jänne, M.D., PhD, Scientific Advisory Board member at TOLREMO and Senior Vice President for Translational Medicine and the Director of the Belfer Center for Applied Cancer Science at the Dana-Farber Cancer Institute and a Professor of Medicine at Harvard Medical School. 'The best-in-class safety and activity in solid tumors is particularly notable because we didn't set out to develop a CBP/p300 inhibitor - initially, TT125-802 was developed phenotypically to inhibit non-oncogene addiction in cancer,' said Stefanie Flückiger-Mangual, PhD, CEO and co-founder of TOLREMO. 'By starting with the biology around transcriptional addiction, it led us to CBP/p300 as a novel target in this space and yielded best-in-class chemistry, enabling a wider therapeutic window and broadening the clinical potential of our asset both in hematological malignancies as well as in solid tumors.' Dr. Jänne and Dr. Omar Saveedra Santa Gadea, a medical oncologist at NEXT Oncology Hospital Quirónsalud in Barcelona, Spain also shared their perspective on the importance of these results, including specific review of clinical case studies as part of an ASCO video update at About TOLREMO TOLREMO therapeutics is pioneering a comprehensive new approach to tackle non-oncogene addiction in cancer by blocking transcriptional escape pathways that operate parallel to the primary oncogene signaling axis. Leveraging our proprietary phenotypic screening platform, we have uncovered a novel role for CBP/p300 as an epigenetic master regulator of transcriptional resistance. Our clinical compound, TT125-802, is an orally available small molecule inhibitor of the bromodomain of CBP/p300 with a differentiated, best-in-class safety profile and activity as single agent in solid tumors. Targeting non-oncogene addiction represents a differentiated strategy to address a major challenge in cancer treatment, with significant therapeutic potential both as a monotherapy as well as in combination with targeted therapies in solid tumors and hematological malignancies. CONTACTS TOLREMO therapeutics AGDr. Stefanie Flückiger-Mangual, CEO and Trophic CommunicationsDr. Stephanie May & Dr. Marie Weickert+ 49 171 185 5682tolremo@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data